These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9651831)

  • 21. Increased antibacterial activity of ZnO nanoparticles: Influence of size and surface modification.
    Lallo da Silva B; Caetano BL; Chiari-Andréo BG; Pietro RCLR; Chiavacci LA
    Colloids Surf B Biointerfaces; 2019 May; 177():440-447. PubMed ID: 30798065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibacterial activity against Streptococcus mutans and diametrical tensile strength of an interim cement modified with zinc oxide nanoparticles and terpenes: An in vitro study.
    Andrade V; Martínez A; Rojas N; Bello-Toledo H; Flores P; Sánchez-Sanhueza G; Catalán A
    J Prosthet Dent; 2018 May; 119(5):862.e1-862.e7. PubMed ID: 29475754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro inhibitory effects of hinokitiol on proliferation of Chlamydia trachomatis.
    Yamano H; Yamazaki T; Sato K; Shiga S; Hagiwara T; Ouchi K; Kishimoto T
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2519-21. PubMed ID: 15917561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time-kill assay results for a linalool-hinokitiol-based eyelid cleanser for lid hygiene.
    Gilbard JP; Douyon Y; Huson RB
    Cornea; 2010 May; 29(5):559-63. PubMed ID: 20308878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mutant selection window in rabbits infected with Staphylococcus aureus.
    Cui J; Liu Y; Wang R; Tong W; Drlica K; Zhao X
    J Infect Dis; 2006 Dec; 194(11):1601-8. PubMed ID: 17083047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial activity and metalloprotease inhibition of hinokitiol-related compounds, the constituents of Thujopsis dolabrata S. and Z. hondai MAK.
    Inamori Y; Shinohara S; Tsujibo H; Okabe T; Morita Y; Sakagami Y; Kumeda Y; Ishida N
    Biol Pharm Bull; 1999 Sep; 22(9):990-3. PubMed ID: 10513629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aloe vera extract functionalized zinc oxide nanoparticles as nanoantibiotics against multi-drug resistant clinical bacterial isolates.
    Ali K; Dwivedi S; Azam A; Saquib Q; Al-Said MS; Alkhedhairy AA; Musarrat J
    J Colloid Interface Sci; 2016 Jun; 472():145-56. PubMed ID: 27031596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of silver/zinc oxide in affecting de-adhesion strength of Staphylococcus aureus on polymer biocomposites.
    Alam F; Balani K
    Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():1106-1114. PubMed ID: 28415396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced activity of carvacrol against biofilm of Staphylococcus aureus and Staphylococcus epidermidis in an acidic environment.
    Nostro A; Cellini L; Zimbalatti V; Blanco AR; Marino A; Pizzimenti F; Di Giulio M; Bisignano G
    APMIS; 2012 Dec; 120(12):967-73. PubMed ID: 23030501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Staphylococcus aureus dry-surface biofilms are not killed by sodium hypochlorite: implications for infection control.
    Almatroudi A; Gosbell IB; Hu H; Jensen SO; Espedido BA; Tahir S; Glasbey TO; Legge P; Whiteley G; Deva A; Vickery K
    J Hosp Infect; 2016 Jul; 93(3):263-70. PubMed ID: 27140421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zinc oxide 3D microstructures as an antimicrobial filler content for composite resins.
    Dias HB; Bernardi MIB; Ramos MADS; Trevisan TC; Bauab TM; Hernandes AC; de Souza Rastelli AN
    Microsc Res Tech; 2017 Jun; 80(6):634-643. PubMed ID: 28271628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial activity of zinc oxide (ZnO) nanoparticle against Klebsiella pneumoniae.
    Reddy LS; Nisha MM; Joice M; Shilpa PN
    Pharm Biol; 2014 Nov; 52(11):1388-97. PubMed ID: 25026353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro analysis of the antibacterial effect of nanohydroxyapatite-ZnO composites.
    Grenho L; Monteiro FJ; Pia Ferraz M
    J Biomed Mater Res A; 2014 Oct; 102(10):3726-33. PubMed ID: 24288156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plectranthus amboinicus leaf extract mediated synthesis of zinc oxide nanoparticles and its control of methicillin resistant Staphylococcus aureus biofilm and blood sucking mosquito larvae.
    Vijayakumar S; Vinoj G; Malaikozhundan B; Shanthi S; Vaseeharan B
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Feb; 137():886-91. PubMed ID: 25280336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.
    Firsov AA; Smirnova MV; Lubenko IY; Vostrov SN; Portnoy YA; Zinner SH
    J Antimicrob Chemother; 2006 Dec; 58(6):1185-92. PubMed ID: 17028094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced adhesion of Staphylococcus aureus to ZnO/PVC nanocomposites.
    Geilich BM; Webster TJ
    Int J Nanomedicine; 2013; 8():1177-84. PubMed ID: 23658484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibacterial activity of ZnO nanoparticles prepared via non-hydrolytic solution route.
    Wahab R; Mishra A; Yun SI; Kim YS; Shin HS
    Appl Microbiol Biotechnol; 2010 Aug; 87(5):1917-25. PubMed ID: 20526594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial potency of single and combined mupirocin and monoterpenes, thymol, menthol and 1,8-cineole against Staphylococcus aureus planktonic and biofilm growth.
    Kifer D; Mužinić V; Klarić MŠ
    J Antibiot (Tokyo); 2016 Sep; 69(9):689-96. PubMed ID: 26883392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison of pharmacokinetics/pharmacodynamics of cefdinir, cefpodoxime proxetil and cefaclor against common bacteria of community acquired infections].
    Xiao YH; Gao L; Li Y; Lü Y; Liu J; Liu Y
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1867-71. PubMed ID: 15631795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.